Synthetic peptide corresponding to Human LILRA4 (internal region).
Séquence
C-SRHILKTLESE
Hôte
Goat
Clonalité
Polyclonal
Isotype
IgG
Conjuguer
Unconjugated
Purification
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Concentration
100 µg at 0.5 mg/ml.
Forme du produit
Liquid
Formulation
Supplied in Tris Buffered Saline, pH 7.30, with 0.02% Sodium Azide and 0.5% BSA.
Stockage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Synonymes
CD85 antigen-like family member G, CD85g, ILT-7, ILT7, Immunoglobulin like transcript 7, Immunoglobulin-like transcript 7, Leukocyte immunoglobulin-like receptor subfamily A member 4, LIRA4_HUMAN, MGC129597, MGC129598
Figure 1: Western Blot - Anti-LILRA4 Antibody (A85256)
Anti-LILRA4 Antibody (A85256) (0.3µg/ml) staining of Human Lymph Node lysate (35µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.
Produits alternatifs à Anti-LILRA4 Anticorps (A85256)